ArgenTAG (Pre-Seed)

Funding Details
Date Award
May 13, 2024
Vertical
Biopharma
Funding URL
View Funding Page

Company Info
Founders
Leandro Ciappina, Pilar Bulacio, Elizabeth Tapia, Ignacio Labari, Joaquin Ezpeleta, Sofía Lavista Llanos, Martina Fernandez
Company Description
ArgenTAG has developed the first truly scalable single-cell solution for long-read sequencers. The company has fundamentally changed the economics of single-cell sequencing by enabling single-cell sequencing to be performed on cheaper 3rd generation long-read DNA sequencers. This paradigm shift will allow the democratization of single-cell sequencing, profoundly affecting how biomedical research is performed and enabling the invention of new long-read applications.
Market
Human Health
Location
Argentina

Links